Debilitating for some, long COVID can lead to cognitive impairment. It persists more than three months after a person experiences the SARS-CoV-2 infection associated with COVID-19. Known as “brain fog,” the post-viral condition encompasses chronic neurological symptoms such as memory failure, headaches, and fatigue, which linger after the infection’s acute stage has passed.
COVID remains a new phenomenon. Therefore, the medical community’s knowledge is rapidly evolving as it researches it. In the early months of the pandemic, direct infection of the brain was one of the suspected reasons for neurological symptoms in patients. However, the medical community could not establish clear evidence of the link between COVID-19 persisting or proliferating in the brain.
Microclots might contribute to long-term COVID-19, impacting blood vessel linings and low serotonin levels. An amino acid-derived chemical, serotonin acts as a hormone and monoamine neurotransmitter. It carries messages in the central nervous system (CNS) that pass among nerve cells within the brain and throughout the body via the peripheral nervous system.
Most serotonin resides in the gastrointestinal tract, and platelets accept it after the tract releases it into the blood system. As part of the food digestion process, the cells lining the intestines produce 90 percent of serotonin, and the brain produces the remaining 10 percent. In addition to regulating bowel function and wound healing capacity, serotonin affects mood and sleep, and the latter may be implicated in brain fog.
Researchers at the Charite Neuropathology Institute in Berlin studying long COVID found that, although the virus may be transmitted by immune cells into the brain, the virus does not directly infect brain cells. They hypothesized that neurological symptoms are a side effect of the massive immune response the body marshals in countering the virus.
In particular, molecular processes appear to change in certain brain cells, activating interferon signaling pathways. This is a typical response when viral infection occurs, as neurons react to an inflammation in a different region of the body. Affected neurotransmitters in the brainstem may be responsible for fatigue, as these are the same cells that regulate mood, motivation, and drive.
Researchers have found a prevalence of reactive nerve cells associated with COVID in the vagus nerve nuclei. The vagus nerve nuclei sit in the brainstem and link with cells that extend to the intestine, lungs, and heart. Although the infection does not directly impact the vagus nerve nuclei, the inflammation in the peripheral organs does disrupt its normal function.
A study published in Nature Neuroscience in February 2024 focused on vascular disruption and disruption of the blood–brain barrier (BBB) function as another possible reason for long COVID. Undertaking a transcriptomic analysis of peripheral blood mononuclear cells among patients with brain fog, researchers found impairment of the coagulation system and adaptive immune response.
As a result of sustained systemic inflammation, paired with BBB dysfunction, brain endothelial cells became inflamed, and the persistence of S protein and other viral components of COVID occurred. With the long-term influence of S protein on cerebrovascular functions still unknown, researchers believe it merits additional investigation.